How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Equine Supplements Market
- By Product Type: Joint Health Supplements, Digestive Health Supplements, Hoof Care Supplements, Electrolytes and Hydration Supplements, Vitamin and Mineral Supplements, Performance Enhancers
- By Formulation: Powder, Pellets, Liquids, Pastilles, Topical Gels and Creams
- By Target Animal: Performance Horses, Recreational Horses, Breeding Horses, Senior Horses, Foals and Young Horses
- By Distribution Channel: Veterinary Clinics, Equine Specialty Stores, Online Retail, Feed Stores, Direct Sales
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Joint Health Supplements leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.171 →
- 11 Company Profiles 17 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Equine Supplements Market report
A complete, evidence-based study - 11 chapters and 121 sections covering market size, segmentation across 4 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Product Type 6
Formulation 5
Target Animal 5
Distribution Channel 5
Companies profiled
Kent Nutrition Group
Nutramax Laboratories Veterinary Sciences Inc.
Boehringer Ingelheim Animal Health
Purina Animal Nutrition LLC
ADM Animal Nutrition
Luitpold Pharmaceuticals Inc.
Manna Pro Products
LLC
Animed International
Vetoquinol SA
Bayer Animal Health
Virbac
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Kent Nutrition Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Nutramax Laboratories Veterinary Sciences Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Boehringer Ingelheim Animal Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Purina Animal Nutrition LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →ADM Animal Nutrition
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Luitpold Pharmaceuticals Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Manna Pro Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Animed International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Vetoquinol SA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Bayer Animal Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Virbac
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Kemin Industries Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Archer Daniels Midland Company
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Cargill
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Incorporated
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Diamond Pet Foods
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$12,632M by 2033 · 11.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Joint Health Supplements26.3
- Digestive Health Supplements16.0
- Hoof Care Supplements16.8
- Electrolytes and Hydration Supplements12.5
- Vitamin and Mineral Supplements13.3
- Performance Enhancers14.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,746M → $4,271M · 11.8%
Europe$1,217M → $2,744M · 10.7%
Asia Pacific$1,111M → $2,378M · 10.0%
Latin America$687.7M → $1,466M · 9.9%
Middle East and Africa$529.0M → $1,317M · 12.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.452026
11.462027
11.472028
11.482029
11.502030
11.512031
11.522032
11.542033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Kent Nutrition Group10.4
- Nutramax Laboratories Veterinary Sciences Inc.12.0
- Boehringer Ingelheim Animal Health12.5
- Purina Animal Nutrition LLC13.1
- ADM Animal Nutrition10.5
- Luitpold Pharmaceuticals Inc.13.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type35.5%
Formulation21.3%
Target Animal26.7%
Distribution Channel16.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.1
- Europe22.5
- Asia Pacific19.5
- Latin America12.0
- Middle East and Africa10.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Kent Nutrition Group | 89 | 79 | 75 | 91 | 97 | 83 | 86 |
| Nutramax Laboratories Veterinary Sciences Inc. | 75 | 87 | 93 | 89 | 86 | 70 | 83 |
| Boehringer Ingelheim Animal Health | 73 | 79 | 69 | 70 | 79 | 87 | 76 |
| Purina Animal Nutrition LLC | 65 | 59 | 69 | 64 | 60 | 67 | 64 |
| ADM Animal Nutrition | 70 | 72 | 62 | 68 | 63 | 55 | 65 |
| Luitpold Pharmaceuticals Inc. | 59 | 55 | 69 | 59 | 70 | 60 | 62 |
| Manna Pro Products | 46 | 62 | 53 | 57 | 50 | 60 | 55 |
| LLC | 52 | 36 | 52 | 43 | 56 | 40 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Kent Nutrition Group
- Nutramax Laboratories Veterinary Sciences Inc.
- Boehringer Ingelheim Animal Health
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Kent Nutrition Group | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Nutramax Laboratories Veterinary Sciences Inc. | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Boehringer Ingelheim Animal Health | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Purina Animal Nutrition LLC | ◐ | − | ◐ | ◐ | ◐ | ◐ |
| ADM Animal Nutrition | ✓ | ◐ | ✓ | ◐ | ◐ | − |
| Luitpold Pharmaceuticals Inc. | − | − | ◐ | ◐ | ◐ | ◐ |
| Manna Pro Products | ◐ | ◐ | ◐ | ◐ | − | − |
| LLC | ◐ | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Kent Nutrition Group86
2Nutramax Laboratories Veterinary Sciences Inc.83
3Boehringer Ingelheim Animal Health76
4ADM Animal Nutrition65
5Purina Animal Nutrition LLC64
6Luitpold Pharmaceuticals Inc.62
7Manna Pro Products55
8LLC47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Kent Nutrition GroupNutramax Laboratories Veterinary Sciences Inc.
Challenger1
Strong scale, closing on the leaders.
Boehringer Ingelheim Animal Health
Contender3
Focused players with pockets of strength.
Purina Animal Nutrition LLCADM Animal NutritionLuitpold Pharmaceuticals Inc.
Niche2
Specialists in a single segment or region.
Manna Pro ProductsLLC
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Equine Supplements Market — a $217M beachhead inside a $2.99B market.
Beachhead (SOM)$217Mobtainable near-term
Serviceable (SAM)$1.17Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Joint Health Supplements
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Digestive Health Supplements
Strong fit — clear ROI and a fast path to value.
End user68 fit
Hoof Care Supplements
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Formulation & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Target Animal
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel29%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Equine Supplements Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified22%
Evaluation15%
Closed-won7%
$15.1KCAC
$58KLTV
3.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Equine Supplements Market is a high-growth opportunity — $6.32B by 2033, compounding at 10.6%.
TAM · 2025$2.81Btoday
TAM · 2033$6.32Bforecast
CAGR10.6%2027–2033
Cumulative$39.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.32BTotal addressable market
SAM$2.43BServiceable available market
SOM$393MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.6% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.32BLarge & growingTAM by 2033 at 10.6% CAGR
$2.43BServiceable nowreachable with today’s model
$393MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.93BBear6.9% CAGR
$6.32BBase10.6% CAGR
$8.08BBull14.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Formulation optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Equine Supplements Market — a $7.61B market by 2033. Plan: grow share from 7.1% to 11.8%.
Market size · 2033$7.61Btotal addressable
Market CAGR6.9%2027–2033
Target share11.8%from 7.1% today
Revenue ambition$898Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.1% | 11.8% | On track |
| Revenue | $563M | $898M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 34.6% | 43.3% | Behind |
| Customer retention | 91.8% | 96.2% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Formulation capability
A defensible second engine — invest in Formulation to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Formulation
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $115M capacity & capability investment
- Greenlight bolt-on M&A in Formulation
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Equine Supplements Market conversation — a $4.76B market you can size, segment and defend in minutes.
Market size · 2033$4.76Btotal opportunity
Growth3.6%CAGR to 2033
Addressable buyers1,766+accounts in scope
Typical ROI5.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.3×return on cost, year one
< 2 mopayback period
$63K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
Kent Nutrition GroupNutramax Laboratories Veterinary Sciences Inc.Boehringer Ingelheim Animal HealthPurina Animal Nutrition LLCADM Animal NutritionLuitpold Pharmaceuticals Inc.Manna Pro ProductsLLC+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Equine Supplements Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Equine Supplements Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Equine Surgical Equipment Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportEquine Therapy Products Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportEquipment Cases Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportEquipment Concrete Admixtures Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportEquipment Docking System Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportEquipment For Oil Refining, Chemical Production Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportEquipment For Riding Horse Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportEquipment Handles Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportEquipment Household Safety Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportEquipment Isolation Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportEquipment Leasing Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportEquipment Market
Market size, share, segmentation and regional forecast.
$596M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.